Navigation Links
bioTheranostics Announces Commercial Agreement With Lab21 to Market THEROS CancerTYPE ID(R) Molecular Cancer Classifier in United Kingdom, Ireland and Middle East Countries
Date:10/6/2009

SAN DIEGO, Oct. 6 /PRNewswire/ -- bioTheranostics, a bioMerieux company that discovers, develops and commercializes new molecular diagnostic tests in oncology, announced that the company has signed a two-year agreement with Lab21 to commercialize the bioTheranostics THEROS CancerTYPE ID molecular cancer classifier in the United Kingdom (UK), Ireland and Middle East countries. The agreement is effective immediately.

Under the terms of the agreement, UK-based Lab21 will market the THEROS CancerTYPE ID (CTID) molecular cancer classifier, while bioTheranostics will perform all sample testing in their CLIA-certified, CAP-accredited laboratory in San Diego, California.

The CTID assay is a 92-gene molecular cancer classifier that identifies 39 different types of tumors and 64 sub-types. It is particularly useful for oncologists and pathologists managing metastatic cancer patients whose primary tumor site (e.g., breast, lung, pancreas) is either "uncertain" or "unknown" following assessment with conventional diagnostics. The results of the CTID assay can guide physicians in selecting optimal therapies for these individuals and potentially improve treatment outcomes. Each year in the UK alone, more than 10,000 people are diagnosed with a cancer of unknown primary origin (aka CUP), and far more patients struggle with a differential diagnosis (i.e., two or more diagnostic options), each of which may lead to a different treatment path.

"We recognize a tremendous need globally for new technologies that will help physicians more quickly and accurately diagnose poorly differentiated and undifferentiated tumors, so that they can determine the optimal therapy for each patient," said Richard Ding, bioTheranostics chief executive officer. "Given Lab21's infrastructure and unique commercial expertise in personalized medicine, we know they are the right partner to deliver the THEROS CancerTYPE ID to doctors and patients in the specified count
'/>"/>

SOURCE bioTheranostics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. One Source Industries Announces Promotion
2. The Symphony Guild Announces Artist Lineup for 2009 Event
3. Hanger Orthopedic Group, Inc. Announces Third Quarter 2009 Earnings Release Conference Call
4. China-Biotics, Inc. Announces Closing of Public Offering of Common Stock
5. Trapeze Networks Announces Trapeze Medical, Bringing Medical-Grade Mobility to Healthcare Market
6. Vertical Measures Announces its Version of Healthcare Reform by Giving Away 5K in Internet Marketing Services
7. Arcxis Biotechnologies Announces Release of First Commercial Product for Molecular Analysis
8. The Pennsylvania Breast Cancer Coalition Announces Request for Applications for Income Tax Check-Off Research Grants
9. NIDDK announces availability of more current kidney disease data
10. APWU Health Plan Announces New Benefits and Premiums for 2010
11. Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 28, 2014 Spine Guide has built ... of information on spinal health. Now, the e-health site ... people suffering from back pain symptoms. Spine Guide specializes ... surgery, and lumbar spine surgery. , Some of the ... or stabbing pain, pain radiating down the leg, inability ...
(Date:8/27/2014)... The National League for Nursing is pleased to ... became the inaugural director of the NLN/Chamberlain College ... of Nursing Education , effective August 11. The center ... for Transformative Excellence, established with the League’s historic move ... Under Dr. Dennis’s leadership, the NLN/Chamberlain Center will expand ...
(Date:8/27/2014)... Recently, Skmen.com, a renowned garment manufacturer ... celebrity bodycon dresses . The company has rich experience ... trendy items in stock and ready to ship: celebrity ... sleeve sweater dresses and so forth. All of them ... , “We are proud to announce the new collection ...
(Date:8/27/2014)... Philadelphia, PA. Inc. magazine ranked ... 500 list, an exclusive ranking of the nation’s fastest-growing ... look at the most important segment of the economy ... early exposure as members of the Inc. 500 list ... , “Some of world’s greatest companies have had their ...
(Date:8/27/2014)... 2014 All Canada Goose Parkas ... go from classic to modern. With unique detailing such as ... them is a step up in opulence. Recently, the company ... Parkas for 2014. , True enough, the new ... great discounts (up to 28% off) on all these brand ...
Breaking Medicine News(10 mins):Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:Skmen.com Unveils Its New Celebrity Bodycon Dresses for Its Loyal Customers 2Health News:Inc Magazine Unveils 33rd Annual List of America's Fastest-Growing Private Companies - the Inc. 500 2Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2
... Anti-fungal and anti-bacterial additives in house paint are present ... the city of Lausanne, says a study to be ... Union (AGU) conference in San Francisco. Chemicals engineered to ... in order to prevent molding and plant growth. Washed ...
... By Alan Mozes HealthDay Reporter , FRIDAY, Dec. ... is just one more form of entertainment. But for Katie ... true cause for celebration. "It was absolute redemption," said ... Michael, 16-year-old son Dylan, and 14-year-old son Dusty -- who ...
... GREENVILLE, S.C. From their fourth-floor state-of-the-art laboratory in ... University bioengineering scientists and students help keep the feet ... new facility, which opens this week, houses one of ... hip, knee and other artificial joints that were removed ...
... certain form of inherited hearing loss have increased ... study by Professor Thomas Jentsch of the Leibniz-Institut ... Medicine (MDC) Berlin-Buch and Professor Gary Lewin (MDC), ... and Nijmegen, the Netherlands. The research findings, which ...
... , FRIDAY, Dec. 9 (HealthDay News) -- Premature infants ... than full-term babies, new research shows. However, the ... Candida fungus, are also more dangerous, researchers from Duke University ... [full-term] infants, whereas in premature infants, they seem to be ...
... were common and long-lasting during the first two ... a new study from Johns Hopkins University School ... factor for impaired physical function. "Early identification ... as a potential,intervention to improve long-term outcomes in ...
Cached Medicine News:Health News:Model shows how façade pollutants make it into the environment 2Health News:Broadway Strikes an Autism-Friendly Chord 2Health News:Broadway Strikes an Autism-Friendly Chord 3Health News:Broadway Strikes an Autism-Friendly Chord 4Health News:Clemson University opens bioengineering research lab at Greenville hospital campus 2Health News:Clemson University opens bioengineering research lab at Greenville hospital campus 3Health News:People with DFNA2 hearing loss show increased touch sensitivity 2Health News:People with DFNA2 hearing loss show increased touch sensitivity 3Health News:Preemies Infected With More Dangerous Types of Bacteria: Study 2Health News:Depressive symptoms and impaired physical function are frequent and long-lasting after ALI 2
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com ... Collaborative R&D Terms & Agreements ... https://www.reportbuyer.com/product/2276220/Collaborative-RD-Terms--Agreements-in-Pharma-Biotech-and-Diagnostics.html The Collaborative R&D ... Diagnostics report provides comprehensive understanding and unprecedented ... agreements entered into by the worlds leading ...
(Date:8/27/2014)... FAIRFAX, Va. , Aug. 27, 2014 ... in the legs due to buildup of fatty plaque ... expected in the aging patient population and in incidences ... Radiology offers its Lower Extremity Arterial RevascularizatioN ... Ariz. Endovascular specialists and interested residents and ...
(Date:8/27/2014)...  Decision Resources Group finds that physicians surveyed ... gastroenterology, endocrinology and nephrology) expect the robustness and ... been assessed in to be the strongest influencers ... Other key findings from the ... of Biosimilars Across Physician Specialties : ...
Breaking Medicine Technology:Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 4Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 5Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 6Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 7Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 8Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics 9LEARN to Treat Peripheral Arterial Disease Patients 2LEARN to Treat Peripheral Arterial Disease Patients 3Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2
... CT Colonography Trial Raise Questions for,Patients, OAK ... CT Colonography Trial, published in the September 18 ... improvements in the technology,s,ability to diagnose intermediate- to ... testing is not as effective in diagnosing small ...
... September 18th New England Journal of,Medicine, Each year ... these deaths could be prevented by regular screening. Yet, ... be screened for the disease are,not being tested - ... with current screening exams., However, results of an ...
Cached Medicine Technology:ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 2ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 3ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 4ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 5MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy 2
Inquire...
Inquire...
Inquire...
One Piece: Premier Pouches - Premier pouches provide the ultimate in skin protection with our long wearing Flextend skin barriers and superior comfort with our soft and silky ComfortWear panels....
Medicine Products: